Precigen, Inc. (FRA:I5X)
Germany
· Delayed Price · Currency is EUR 3.146
+0.178 (6.00%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Exemplar | 6.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exemplar Growth | -48.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceuticals | 75.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biopharmaceuticals Growth | -99.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trans Ova | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trans Ova Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Human Biotherapeutics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ActoBio | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ActoBio Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| PGEN Therapeutics, Inc. | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| PGEN Therapeutics, Inc. Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MBP Titan | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| United States | 6.23M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -76.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Foreign | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Foreign Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|